Generation Bio Co. (GBIO) Prices 10.526M Share IPO at $19/Sh

Generation Bio Co. (NASDAQ: GBIO) today announced the pricing of its initial public offering of 10,526,316 shares of its common stock at an initial public offering price of $19.00 per share. In addition, Generation Bio has granted the underwriters a 30-day option to purchase up to 1,578,947 additional shares of common stock at the initial public offering price, less the underwriting discount and commissions. All of the shares are being offered by Generation Bio.

Generation Bio has been approved for listing on the Nasdaq Global Select Market and is expected to begin trading on Friday, June 12, 2020 under the ticker symbol “GBIO.” The gross proceeds of the offering, before deducting the underwriting discount and commissions and other offering expenses payable by Generation Bio, are expected to be approximately $200 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on Tuesday, June 16, 2020, subject to customary closing conditions.

J.P. Morgan, Jefferies, and Cowen are acting as joint bookrunning managers for the offering. Wedbush PacGrow is acting as lead manager for the offering.

You May Also Be Interested In

• Londian Wason New Energy Tech opens at $26, above IPO price of $22
• Lyntris (LYNX) files for 24M share IPO at $19-$22/sh
• BOA Acquisition Corp. II raises $143.75M in Nasdaq IPO